Abstract:The symbiotic relationship between the human digestive system and its intricate microbiota is a captivating field of study that continues to unfold. Comprising predominantly anaerobic bacteria, this complex microbial ecosystem, teeming with trillions of organisms, plays a crucial role in various physiological processes. Beyond its primary function in breaking down indigestible dietary components, this microbial community significantly influences immune system modulation, central nervous system function, and disease prevention. Despite the strides made in microbiome research, the precise mechanisms underlying how bacterial effector functions impact mammalian and microbiome physiology remain elusive. Unlike the traditional DNA-RNA-protein paradigm, bacteria often communicate through small molecules, underscoring the imperative to identify compounds produced by human-associated bacteria. The gut microbiome emerges as a linchpin in the transformation of natural products, generating metabolites with distinct physiological functions. Unraveling these microbial transformations holds the key to understanding the pharmacological activities and metabolic mechanisms of natural products. Notably, the potential to leverage gut microorganisms for large-scale synthesis of bioactive compounds remains an underexplored frontier with promising implications. This review serves as a synthesis of current knowledge, shedding light on the dynamic interplay between natural products, bacteria, and human health. In doing so, it contributes to our evolving comprehension of microbiome dynamics, opening avenues for innovative applications in medicine and therapeutics. As we delve deeper into this intricate web of interactions, the prospect of harnessing the power of the gut microbiome for transformative medical interventions becomes increasingly tantalizing.

Advances in synthetic biology toolboxes paving the way for mechanistic understanding and strain engineering of gut commensal Bacteroides spp. and Clostridium spp.

Streamlined Genetic Manipulation of Diverse Bacteroides and Parabacteroides Isolates from the Human Gut Microbiota

Engineered Live Biotherapeutics: Progress and Challenges

Engineer Probiotic Bifidobacteria for Food and Biomedical Applications - Current Status and Future Prospective.

Genome engineering of the human gut microbiome

Metabolic Engineering of Commensal Bacteria for Gut Butyrate Delivery and Dissection of Host-Microbe Interaction.

Chemical genetic approaches to dissect microbiota mechanisms in health and disease

A Toolbox for Genetic Manipulation in Intestinal Clostridium Symbiosum

Recent advances in host-focused molecular tools for investigating host-gut microbiome interactions

Decoding the microbiome: advances in genetic manipulation for gut bacteria

Engineering the gut microbiome

Commensal inter-bacterial interactions shaping the microbiota

Genetic manipulation of gut microbes enables single-gene interrogation in a complex microbiome

Engineered Cancer Targeting Microbes and Encapsulation Devices for Human Gut Microbiome Applications

Small molecules in the big picture of gut microbiome-host cross-talk

Large-scale chemical-genetics of the human gut bacterium Bacteroides thetaiotaomicron

Targeted Approaches for In Situ Gut Microbiome Manipulation

Statistical design of a synthetic microbiome that clears a multi-drug resistant gut pathogen

CRISPR/Cas-Based Genome Editing for Human Gut Commensal Bacteroides Species

Genomic Insights into Probiotic Metabolism of Dietary Carbohydrates, Proteins, and Fats

Microbiota, natural products, and human health: exploring interactions for therapeutic insights